SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $347,000 | -92.3% | 13,258 | -92.6% | 0.00% | -94.1% |
| Q4 2020 | $4,494,000 | -48.3% | 178,589 | -57.2% | 0.02% | -52.8% |
| Q3 2020 | $8,700,000 | -45.4% | 417,461 | -37.8% | 0.04% | -47.8% |
| Q2 2020 | $15,934,000 | +110.6% | 670,915 | +59.6% | 0.07% | +60.5% |
| Q1 2020 | $7,565,000 | -23.9% | 420,448 | +0.4% | 0.04% | -4.4% |
| Q4 2019 | $9,937,000 | -31.5% | 418,929 | -20.6% | 0.04% | -27.4% |
| Q3 2019 | $14,500,000 | -25.5% | 527,575 | -10.3% | 0.06% | -33.3% |
| Q2 2019 | $19,471,000 | -24.3% | 588,401 | -19.9% | 0.09% | -16.2% |
| Q1 2019 | $25,734,000 | +6.8% | 734,398 | +1.3% | 0.11% | -6.7% |
| Q4 2018 | $24,087,000 | -45.2% | 725,034 | -16.9% | 0.12% | -34.6% |
| Q3 2018 | $43,950,000 | -34.6% | 872,890 | -22.2% | 0.18% | -37.2% |
| Q2 2018 | $67,153,000 | +28.6% | 1,122,005 | -1.6% | 0.29% | +28.3% |
| Q1 2018 | $52,231,000 | +2.4% | 1,140,419 | -10.9% | 0.23% | +2.3% |
| Q4 2017 | $51,013,000 | +1.6% | 1,280,179 | +2.0% | 0.22% | -0.5% |
| Q3 2017 | $50,226,000 | -25.2% | 1,255,688 | -19.4% | 0.22% | -27.0% |
| Q2 2017 | $67,132,000 | +32.3% | 1,557,544 | -3.9% | 0.30% | +31.0% |
| Q1 2017 | $50,732,000 | +20.9% | 1,620,798 | -2.5% | 0.23% | +13.7% |
| Q4 2016 | $41,969,000 | -2.3% | 1,662,099 | -4.3% | 0.20% | -4.2% |
| Q3 2016 | $42,967,000 | +38.1% | 1,737,526 | +13.8% | 0.21% | +34.0% |
| Q2 2016 | $31,110,000 | +39.8% | 1,527,277 | +4.7% | 0.16% | +42.0% |
| Q1 2016 | $22,259,000 | +1.5% | 1,459,407 | -10.6% | 0.11% | -2.6% |
| Q4 2015 | $21,940,000 | +117.3% | 1,632,683 | +126.9% | 0.12% | +109.1% |
| Q3 2015 | $10,096,000 | -1.4% | 719,554 | +19.3% | 0.06% | +10.0% |
| Q2 2015 | $10,239,000 | – | 603,020 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |